• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Varex Imaging Corporation

    12/31/24 9:08:24 PM ET
    $VREX
    Industrial Machinery/Components
    Technology
    Get the next $VREX alert in real time by email
    DEFA14A 1 tm2424275-12_defa14a.htm DEFA14A tm2424275-12_defa14a - none - 1.3593876s
    ​
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 14A
    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934 (Amendment No. 1)
    Filed by the Registrant ☒
    Filed by a Party other than the Registrant ☐
    Check the appropriate box:
    ☐
    Preliminary Proxy Statement
    ​
    ☐
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ​
    ☐
    Definitive Proxy Statement
    ​
    ☒
    Definitive Additional Materials
    ​
    ☐
    Soliciting Material under §240.14a-12
    ​
    VAREX IMAGING CORPORATION
    ​
    (Name of Registrant as Specified In Its Charter)​
    ​
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)​
    Payment of Filing Fee (Check all boxes that apply):
    ☒
    No fee required.
    ​
    ☐
    Fee paid previously with preliminary materials.
    ​
    ☐
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
    ​

    ​
     
    [MISSING IMAGE: lg_vareximaging-4c.jpg]
    ​
    AMENDMENT TO THE PROXY STATEMENT DATED DECEMBER 30, 2024
    FOR THE ANNUAL MEETING OF STOCKHOLDERS
    TO BE HELD ON FEBRUARY 13, 2025
    The following information amends and replaces certain disclosures in the definitive proxy statement of Varex Imaging Corporation (the “Company”) filed with the U.S. Securities and Exchange Commission on December 30, 2024 (the “Proxy Statement”) and furnished to stockholders of the Company in connection with the solicitation of proxies by the Board of Directors of the Company for the 2025 Annual Meeting of Stockholders of the Company, to be held as a virtual meeting conducted via a live audio webcast at www.virtualshareholdermeeting.com/VREX2025 on February 13, 2025 commencing at 4:30 p.m. Mountain Time, and any adjournment or postponement thereof (the “Annual Meeting”).
    The Company is filing this Amendment No. 1 to the Proxy Statement (this “Amendment”) to clarify the treatment of broker non-votes with respect to Proposal 5 regarding the approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to provide for officer exculpation to the extent permitted under Delaware law.
    Q: What are abstentions and broker non-votes and how do they affect voting?
    The text below amends and replaces, in its entirety, the answer given under the question “Q: What are abstentions and broker non-votes and how do they affect voting?” on page 6 of the Proxy Statement:
    A:
    Abstentions — If you specify that you wish to “abstain” from voting on an item, your shares will not be voted on that item. Abstentions are counted toward establishing a quorum. Abstentions have no effect on the election of directors but are included in the shares entitled to vote on Proposals Two through Six. On Proposals Two through Six abstentions have the effect of a vote against the proposal.
    ​
    Broker Non-Votes — If your broker holds your shares in its name and does not receive voting instructions from you, your broker has discretion to vote these shares on certain “routine” matters, such as the ratification of the appointment of the independent registered public accounting firm. However, on non- routine matters such as the election of directors and the advisory vote to approve executive compensation, your broker must receive voting instructions from you, as your broker does not have discretionary voting power for those particular items. So long as the broker has discretion to vote on at least one proposal, these “broker non-votes” are counted toward establishing a quorum but will have no effect on the proposal because they are not “entitled to vote” on the matter, with the exception that a broker non-vote will have the effect of a vote against Proposal Five. When voted on “routine” matters, broker non-votes are counted toward determining the outcome of that “routine” matter.
     

    ​
     
    Except as described above, this Amendment does not modify, amend, supplement, revise, replace, update or otherwise affect any of the other disclosures in the Proxy Statement, which continues to speak as of December 30, 2024. This Amendment does not provide all of the information that is important to your voting decisions at the Annual Meeting and should be read in conjunction with the Proxy Statement, which contains other important information. From and after the date of this Amendment, any references to the “Proxy Statement” are to the Proxy Statement as amended hereby.
    If you have already voted, you do not need to vote again unless you would like to change or revoke your prior vote on any proposal. If you would like to change or revoke your prior vote on any proposal, please refer to the paragraph under the question “Q: How do I vote and how do I revoke my proxy?” on page 5 of the Proxy Statement for instructions on how to do so.
     

    Get the next $VREX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VREX

    DatePrice TargetRatingAnalyst
    8/23/2024$21.00Buy
    B. Riley Securities
    10/12/2022$24.00Hold
    Jefferies
    More analyst ratings

    $VREX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Varex Announces Financial Results for First Quarter Fiscal Year 2026

    Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter fiscal year 2026. Q1FY26 Summary Revenues $210 million GAAP gross margin 33% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net income $0.05 per diluted share | Non-GAAP net income* $0.19 per diluted share Cash outflow from operations of $16 million "We are pleased to report a solid start to fiscal 2026, with results toward the high-end of guidance. First quarter revenue of $210 million, increased 5% year-over-year. Growth in the quarter was driven by strength in our cargo systems business, which contributed to a 17% ye

    2/10/26 4:05:00 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Varex Schedules First Quarter Fiscal Year 2026 Earnings Release and Conference Call

    Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2026, following the close of regular trading on Tuesday, February 10, 2026. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from February 10th t

    1/27/26 9:05:00 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Varex to Participate in CJS Securities 26th Annual New Ideas for the New Year Conference

    Varex Imaging Corporation (NASDAQ:VREX) announced today that management is scheduled to present at the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference. Management will be presenting on Wednesday, January 14, 2026 at 3:50pm ET. The webcast can be accessed here or on Varex's website at www.vareximaging.com/news. About Varex Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems, as well as X-ray imaging systems for industrial applications. With a 70+ year history of successful innov

    1/6/26 9:05:00 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $VREX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Maheshwari Shubham bought $108,200 worth of shares (10,000 units at $10.82), increasing direct ownership by 22% to 56,063 units (SEC Form 4)

    4 - Varex Imaging Corp (0001681622) (Issuer)

    8/14/24 4:42:34 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Chief Financial Officer Maheshwari Shubham bought $98,897 worth of shares (9,007 units at $10.98), increasing direct ownership by 24% to 46,063 units (SEC Form 4)

    4 - Varex Imaging Corp (0001681622) (Issuer)

    8/12/24 4:33:04 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $VREX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kunkel Jay K. converted options into 8,483 shares, increasing direct ownership by 44% to 27,960 units (SEC Form 4)

    4 - Varex Imaging Corp (0001681622) (Issuer)

    2/10/26 4:04:29 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Director Bardwell Kathleen converted options into 8,483 shares, increasing direct ownership by 234% to 12,102 units (SEC Form 4)

    4 - Varex Imaging Corp (0001681622) (Issuer)

    2/9/26 4:14:10 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Director Chertoff Jocelyn D converted options into 8,483 shares, increasing direct ownership by 25% to 42,194 units (SEC Form 4)

    4 - Varex Imaging Corp (0001681622) (Issuer)

    2/9/26 4:15:00 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $VREX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Varex Imaging with a new price target

    B. Riley Securities initiated coverage of Varex Imaging with a rating of Buy and set a new price target of $21.00

    8/23/24 7:39:01 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Jefferies initiated coverage on Varex Imaging with a new price target

    Jefferies initiated coverage of Varex Imaging with a rating of Hold and set a new price target of $24.00

    10/12/22 9:08:06 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Varex Imaging upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Varex Imaging from Market Perform to Outperform and set a new price target of $35.50

    2/5/21 8:31:02 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $VREX
    SEC Filings

    View All

    SEC Form 10-Q filed by Varex Imaging Corporation

    10-Q - Varex Imaging Corp (0001681622) (Filer)

    2/10/26 4:08:51 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Varex Imaging Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Varex Imaging Corp (0001681622) (Filer)

    2/10/26 4:06:33 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    SEC Form DEFA14A filed by Varex Imaging Corporation

    DEFA14A - Varex Imaging Corp (0001681622) (Filer)

    12/29/25 4:09:54 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $VREX
    Financials

    Live finance-specific insights

    View All

    Varex Announces Financial Results for First Quarter Fiscal Year 2026

    Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the first quarter fiscal year 2026. Q1FY26 Summary Revenues $210 million GAAP gross margin 33% | Non-GAAP gross margin* 34% GAAP operating margin 7% | Non-GAAP operating margin* 9% GAAP net income $0.05 per diluted share | Non-GAAP net income* $0.19 per diluted share Cash outflow from operations of $16 million "We are pleased to report a solid start to fiscal 2026, with results toward the high-end of guidance. First quarter revenue of $210 million, increased 5% year-over-year. Growth in the quarter was driven by strength in our cargo systems business, which contributed to a 17% ye

    2/10/26 4:05:00 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Varex Schedules First Quarter Fiscal Year 2026 Earnings Release and Conference Call

    Varex Imaging Corporation (NASDAQ:VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2026, following the close of regular trading on Tuesday, February 10, 2026. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from February 10th t

    1/27/26 9:05:00 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025

    Varex Imaging Corporation (NASDAQ:VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2025. Q4FY25 Summary Revenues $229 million GAAP gross margin 34% | Non-GAAP gross margin* 34% GAAP operating margin 9% | Non-GAAP operating margin* 10% GAAP net income $0.29 per diluted share | Non-GAAP net income* $0.37 per diluted share Cash flow from operations was $8 million FY25 Summary Revenues $845 million GAAP gross margin 34% | Non-GAAP gross margin* 35% GAAP operating margin (3)% | Non-GAAP operating margin* 9% GAAP net loss $(1.70) per diluted share | Non-GAAP net income* $0.90 per diluted share Cash flow from operations

    11/18/25 4:05:00 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    $VREX
    Leadership Updates

    Live Leadership Updates

    View All

    CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors

    SAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today that the Company's Board of Directors (the "Board") has appointed Walter (Walt) M Rosebrough, Jr. as an independent director, effective as of January 3, 2026. In connection with this appointment, the Company also has entered into a cooperation agreement (the "Cooperation Agreement") with Browning West, LP. ("Browning West"). Mr. Rosebrough will join the Board's Corporate Governance & Nominating Committee. The Board has also agreed that, by the end of 2026, it shall provide due and serious consideration for Mr. Rosebrough to be appointed Chair of the Board. In

    12/23/25 8:00:00 AM ET
    $COO
    $STE
    $VREX
    Ophthalmic Goods
    Health Care
    Industrial Specialties
    Industrial Machinery/Components

    Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from

    9/6/24 6:43:00 PM ET
    $AAL
    $ADMA
    $ADNT
    Air Freight/Delivery Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $VREX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Varex Imaging Corporation

    SC 13G/A - Varex Imaging Corp (0001681622) (Subject)

    11/12/24 5:44:53 PM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SC 13G/A filed by Varex Imaging Corporation

    SC 13G/A - Varex Imaging Corp (0001681622) (Subject)

    11/4/24 10:46:57 AM ET
    $VREX
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SC 13G/A filed by Varex Imaging Corporation

    SC 13G/A - Varex Imaging Corp (0001681622) (Subject)

    10/9/24 1:00:59 PM ET
    $VREX
    Industrial Machinery/Components
    Technology